Showing results (21-30 of 92) with videos related to
Sort By:
Pageof 10
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 14, 2021
CAR T-Cell Therapy in Hematologic Malignancies: Clinical Role, Toxicity, and Unanswered QuestionsSaar Gill, Jennifer N BrudnoClinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 16, 2018
Novel Approaches to Acute Myeloid Leukemia ImmunotherapyOfrat Beyar-Katz, Saar GillSeminars in Hematology|March 31, 2019
Will CAR T cell therapy have a role in AML? Promises and pitfallsKatherine D Cummins, Saar GillPlos Pathogens|August 11, 2011
EBV latency types adopt alternative chromatin conformationsItalo Tempera, Michael Klichinsky, Paul M LiebermanScience Translational Medicine|September 10, 2025
Impaired TIM4-mediated efferocytosis by liver macrophages contributes to fibrosis in metabolic dysfunction-associated steatohepatitisHongxue Shi, Xiaobo Wang, Christopher Sloas, et al.Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|September 18, 2016
Chimeric Antigen Receptor T Cells and Hematopoietic Cell Transplantation: How Not to Put the CART Before the HorseSaad S Kenderian, David L Porter, Saar GillBiology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|June 23, 2009
Natural killer cells in allogeneic transplantation: effect on engraftment, graft- versus-tumor, and graft-versus-host responsesSaar Gill, Janelle A Olson, Robert S NegrinMethods in Molecular Biology (Clifton, N.J.)|July 24, 2017
Generating and Expanding Autologous Chimeric Antigen Receptor T Cells from Patients with Acute Myeloid LeukemiaSaad S Kenderian, Carl H June, Saar GillCurrent Opinion in Oncology|December 17, 2009
Biology and clinical effects of natural killer cells in allogeneic transplantationJonathan E Benjamin, Saar Gill, Robert S NegrinBlood Reviews|November 18, 2015
Chimeric antigen receptor T cell therapy: 25years in the makingSaar Gill, Marcela V Maus, David L PorterPageof 10